How will blockchain impact pharma?

blockchain_network_big

At first glance, the global pharmaceutical industry, often regarded as slow-moving, conservative and resistant to change, appears infertile ground for an innovation like blockchain to take hold.

In the common imagination, blockchain is associated with Bitcoin and related so-called ‘cryptocurrencies’ -  the wild west of financial markets that many in the sector have ruled out as being unstable and unsustainable.

But while cryptocurrencies may have an uncertain future, the underlying technology that makes them possible is a safer bet.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical